June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

November 24, 2014November 24, 2014

Study Finds IL28B Polymorphism In Melanoma Patients Is Not A Predictor For Interferon Alpha Treatment

News

In a recent study titled “IL28B Polymorphism Cannot Predict Response to Interferon Alpha Treatment in Patients with Melanoma”, published in PlosOne, a team of researchers led by Dr. Katharina Grabmeier-Pfistershammer, ... Read more

November 21, 2014November 21, 2014

Study Finds Interactions Between UV Light and Genetic Variants Determinant For Childhood Nevus and Freckles

News

In a recent study titled “Interactions between Ultraviolet Light andMC1R and OCA2 Variants Are Determinants of Childhood Nevus and Freckle Phenotypes”, published in the Cancer Epidemiology, Biomarkers & Prevention journal, a research team ... Read more

November 20, 2014

Study Evaluates Solar Elastosis And Cutaneous Melanoma

News

In a recent study titled “Solar elastosis and cutaneous melanoma: a site-specific analysis”, published ahead of print in the International Journal of Cancer, a research team led by Dr. David ... Read more

November 19, 2014November 19, 2014

Study Finds Combination of Dabrafenib and Trametinib Improves Overall Survival in Metastatic Melanoma Patients

News

In a recent article entitled “Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib” published in The New England Journal of Medicine, a team of researchers lead by Caroline ... Read more

November 17, 2014November 17, 2014

Bristol-Myers Immunotherapy Opdivo Shows Promising Results In The Treatment Of Advanced Melanoma

News

During the Society for Melanoma Research 2014 International Congress in Zurich, Switzerland, Bristol-Myers Squibb (BMS) presented the results of its CheckMate-066 trial, a Phase 3 randomized, double-blind study comparing Opdivo (nivolumab) to ... Read more

November 14, 2014

Genetic Testing For Melanoma Risk Could Help With Prevention, According to Study

News

A recent study published in the JAMA Dermatology journal, entitled “Family Risk Discussions After Feedback on Genetic Risk of Melanoma” found that positive information on the genetic risk of melanoma ... Read more

November 13, 2014

Study Shows Efficacy Of Melanoma Drug TAK-733

News

A recent study entitled “Antitumor Activity of the MEK Inhibitor TAK-733 Against Melanoma Cell Lines and Patient-Derived Tumor Explants”, published in the journal Molecular Cancer Therapeutics, investigated the activity of ... Read more

November 12, 2014

Tumor Thickness Indicates 10-Year Survival for Mucosal Melanoma

Melanoma, News

When thinking of melanoma, skin cancer due to ultraviolet radiation usually comes to mind. Less commonly, about 1% of melanoma patients can develop mucosal melanoma, which is associated with a ... Read more

November 11, 2014

OHSU To Host The Community Melanoma Registry

News

Oregon Health & Science University will host a half-day symposium at the OHSU Doernbecher Children’s Hospital to discuss the latest melanoma treatments and hear from melanoma survivors. The OHSU Community ... Read more

November 10, 2014November 10, 2014

Study Finds Discordancy in BRAF Mutations Among Primary And Metastatic Melanoma Lesions

News

One of the commonly used treatments for patients diagnosed with BRAF V600 mutation-positive melanoma with unresectable stage III and IV disease includes selective BRAF inhibitor with or without a MEK ... Read more

November 7, 2014November 7, 2014

University of Pittsburgh to Open Multiple Melanoma Tissue Banks

News

Human tissue sample banks have been an integral source of research material in the ongoing mission to find better treatments for today’s diseases. These banks house a myriad of samples ... Read more

November 7, 2014November 7, 2014

OncoSec To Present Latest Clinical Data at Melanoma Bridge 2014

News

During the 2014 Melanoma Bridge meeting in Italy, OncoSec Medical Inc., a company focusing on the development of DNA-based intratumoral cancer immunotherapies, will present its most recent data resultant from ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group